Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.
Int J Cardiol. 2013 Sep 20;168(1):112-6. doi: 10.1016/j.ijcard.2012.09.061. Epub 2012 Oct 17.
Several epidemiological reports indicate that the body mass index (BMI) is inversely related with mortality, in spite of the notion that obesity is a recognized cardio-metabolic risk factor. The aim of the study was to evaluate the independent impact of overweight and obesity on long-term mortality in a large cohort of patients with heart disease (HD).
The study included 10,446 patients hospitalized in the last three decades for ischemic (60%) or non-ischemic HD and followed-up for 10 years. The relationship between BMI and total or cardiovascular mortality was analyzed in the whole cohort, and in age-stratified categories (≤ 65 and >65 years). Considering that survival in HD patients has improved after the introduction of revascularization, beta-blockers, ACE inhibitors, and statins, the relationship was re-examined separately in patients hospitalized before and after 1990.
Diabetes, hyperuricemia, hypertension, glycaemia, and triglyceridemia increased across BMI groups. During follow-up (73 ± 59 months) there were 1707 all-cause deaths (47% cardiac). Any relationship between BMI and mortality was lost in the ≤ 65 age category and in patients hospitalized before 1990, but it persisted in old patients hospitalized after 1990. Most significant independent predictors of mortality in all groups were hyperuricemia, diabetes and impaired ejection fraction.
No independent relationship was found between BMI and mortality in subjects ≤ 65 years of age. This neutral relationship seems to be partly counteracted by treatment, particularly in old patients. A different effect of obesity onset in old vs. young age cannot be ruled out.
几项流行病学报告表明,尽管肥胖是公认的心血管代谢危险因素,但体重指数(BMI)与死亡率呈负相关。本研究的目的是评估超重和肥胖对患有心脏病(HD)的大样本患者长期死亡率的独立影响。
该研究纳入了过去三十年中因缺血性(60%)或非缺血性 HD 住院的 10446 例患者,并进行了 10 年的随访。在整个队列中以及在年龄分层类别(≤65 岁和>65 岁)中分析了 BMI 与全因或心血管死亡率之间的关系。考虑到血管重建术、β受体阻滞剂、血管紧张素转换酶抑制剂和他汀类药物的应用改善了 HD 患者的生存率,因此分别在 1990 年前和 1990 年后住院的患者中重新检查了这种关系。
糖尿病、高尿酸血症、高血压、血糖和甘油三酯随着 BMI 组的增加而增加。在随访期间(73±59 个月),共有 1707 例全因死亡(47%为心脏性死亡)。BMI 与死亡率之间的任何关系在≤65 岁年龄组和 1990 年前住院的患者中均丧失,但在 1990 年后住院的老年患者中仍持续存在。所有组中死亡率的最重要独立预测因素是高尿酸血症、糖尿病和射血分数受损。
在≤65 岁的患者中,BMI 与死亡率之间未发现独立关系。这种中性关系似乎部分被治疗所抵消,尤其是在老年患者中。不能排除肥胖在老年和年轻患者中发生作用的不同。